top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
The $800 million pill [[electronic resource] ] : the truth behind the cost of new drugs / / Merrill Goozner
The $800 million pill [[electronic resource] ] : the truth behind the cost of new drugs / / Merrill Goozner
Autore Goozner Merrill <1950->
Pubbl/distr/stampa Berkeley, : University of California Press, 2004
Descrizione fisica 1 online resource (304 p.)
Disciplina 338.4/3/61510973
Soggetto topico Prescription pricing
Drugs - Prices
Pharmaceutical industry
Consumer education
Soggetto genere / forma Electronic books.
ISBN 1-282-35824-3
9786612358241
0-520-93928-X
1-59734-450-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index
Altri titoli varianti Eight hundred million dollar pill
Record Nr. UNINA-9910456407003321
Goozner Merrill <1950->  
Berkeley, : University of California Press, 2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner
The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner
Autore Goozner Merrill <1950->
Pubbl/distr/stampa Berkeley : , : University of California Press, , 2004
Descrizione fisica 1 online resource (304 pages)
Disciplina 338.4/3/61510973
Soggetto topico Prescription pricing
Drugs - Prices
Pharmaceutical industry
Consumer education
Soggetto non controllato american society
biochemists
biotech drugs
drug companies
drug cost
drug culture
drug funding
drug innovation
drug manufacturing
drug pricing
expose piece
genetic disorders
government funded research
high costs
human genome project
investments
medical breakthroughs
medical innovations
medical research
pharmaceutical companies
prescription drugs
private sector
public heath
public sector
research and development
us government
ISBN 1-282-35824-3
9786612358241
0-520-93928-X
1-59734-450-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index
Altri titoli varianti Eight hundred million dollar pill
Record Nr. UNINA-9910780445003321
Goozner Merrill <1950->  
Berkeley : , : University of California Press, , 2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner
The $800 million pill : the truth behind the cost of new drugs / / Merrill Goozner
Autore Goozner Merrill <1950->
Edizione [1st ed.]
Pubbl/distr/stampa Berkeley, : University of California Press, 2004
Descrizione fisica 1 online resource (304 pages)
Disciplina 338.4/3/61510973
Soggetto topico Prescription pricing
Drugs - Prices
Pharmaceutical industry
Consumer education
ISBN 1-282-35824-3
9786612358241
0-520-93928-X
1-59734-450-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front matter -- Contents -- Introduction -- PART ONE. BIOHYPE -- PART TWO. DIRECTED RESEARCH -- PART THREE. BIG PHARMA -- Notes -- Bibliography -- Acknowledgments -- Index
Altri titoli varianti Eight hundred million dollar pill
Record Nr. UNINA-9910814843603321
Goozner Merrill <1950->  
Berkeley, : University of California Press, 2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Brand-name prescription drug pricing [[electronic resource] ] : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters
Brand-name prescription drug pricing [[electronic resource] ] : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters
Pubbl/distr/stampa [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2009]
Descrizione fisica 1 online resource (ii, 35 pages)
Soggetto topico Prescription pricing
Brand name products - Prices
Prescription pricing - Government policy - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Brand-name prescription drug pricing
Record Nr. UNINA-9910697037703321
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2009]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Competition and the cost of Medicare's prescription drug program
Competition and the cost of Medicare's prescription drug program
Autore Cook Anna
Pubbl/distr/stampa [Washington, D.C.] : , : Congress of the United States, Congressional Budget Office, , 2014
Descrizione fisica 1 online resource (ii, 44 pages) : color illustrations
Soggetto topico Pharmaceutical services insurance - United States
Prescription pricing - United States
Drugs - Prices - United States
Medical care, Cost of - United States
Medicare
Pharmaceutical services insurance
Prescription pricing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910717333403321
Cook Anna  
[Washington, D.C.] : , : Congress of the United States, Congressional Budget Office, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018
The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2020
Descrizione fisica 1 online resource (iii, 41 pages)
Collana S. hrg.
Soggetto topico Drugs - United States - Cost control
Pharmaceutical policy - United States
Prescription pricing - United States
Drugs - Cost control
Pharmaceutical policy
Prescription pricing
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Cost of Prescription Drugs
Record Nr. UNINA-9910714807303321
Washington : , : U.S. Government Publishing Office, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005
Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005
Descrizione fisica 1 online resource (iii, 105 p.) : ill
Soggetto topico Drug reimportation - United States
Prescription pricing - United States
Drugs - Purchasing - United States
Pharmaceutical policy - United States
Foreign trade regulation - United States
Drug reimportation
Drugs - Purchasing
Foreign trade regulation
Pharmaceutical policy
Prescription pricing
Soggetto non controllato Pricing
Drugs
Pharmaceutical policy
Foreign trade regulation
Business & economics
Medical
Political science
Law
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Drug Importation
Record Nr. UNINA-9910694099103321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging health care issues : follow-on biologic drug competition
Emerging health care issues : follow-on biologic drug competition
Pubbl/distr/stampa Washington, DC : , : Federal Trade Commission, , 2009
Descrizione fisica 1 online resource (120 unnumbered pages) : color illustrations
Collana Federal Trade Commission report
Soggetto topico Biologicals
Drugs - Prices
Prescription pricing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Emerging Health Care Issues
Record Nr. UNINA-9910702957203321
Washington, DC : , : Federal Trade Commission, , 2009
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica 1 online resource (ii, 39 pages) : illustrations
Collana S. hrg.
Soggetto topico Generic drugs - Prices - United States
Drugs - Prices - United States
Prescription pricing - United States
Drug accessibility - Government policy - United States
Drugs - Generic substitution
Drug approval - United States
Drug approval
Drugs - Prices
Generic drugs - Prices
Prescription pricing
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Generic drug user fee amendments
Record Nr. UNINA-9910706703803321
Washington : , : U.S. Government Publishing Office, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2021
Descrizione fisica 1 online resource (iv, 175 pages) : color illustrations
Soggetto topico Prescription pricing - United States
Drugs - Prices - United States
Pharmaceutical industry - United States
Social responsibility of business - United States
Drugs - Prices
Pharmaceutical industry
Prescription pricing
Social responsibility of business
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Making health care more affordable
Record Nr. UNINA-9910715252803321
Washington : , : U.S. Government Publishing Office, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui